Mdm2 binding to a conformationally sensitive domain on p53 can be modulated by RNA

FEBS Letters

Volumn 472, Issue 1, 2000, Pages 93-98

  Burch, L R ^a   Midgley, C A ^b   Currie, R A ^a   Lane, D P ^a   Hupp, T R ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Deletion mutation; Mdm2; p53 conformation; RNA

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; DELETION MUTANT; DNA BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RNA BINDING;

BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MUTATION, MISSENSE; NUCLEAR PROTEINS; POINT MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA; SURFACE PLASMON RESONANCE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034697107     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(00)01427-7     Document Type: Article

References (30)

1. Honda R., Tanaka H., Yasuda H. FEBS Lett. 420:1997;25-27.
2. Bottger A., Bottger V., Garcia-Echeverria C., Chene P., Hochkeppel H.-K., Sampson W., Ang K., Howard S.F., picksley S.M., Lane D.P. J. Mol. Biol. 269:1997;744-759.
3. Blaydes J.P., Wynford-Thomas D. Oncogene. 16:1998;3317-3322.
4. Hupp T.R., Sparks A., Lane D.P. Cell. 83:1995;237-245.
5. Abarzua P., LoSardo J.E., Gubler M.L., Spathis R., Lu Y.A., Felix A., Neri A. Oncogene. 13:1996;2477-2482.
6. Selivanova G., Iotsova V., Okan I., Fritsche M., Strom M., Groner B., Grafstrom R.C. Nat. Med. 3:1997;632-638.
7. Caron de Fromentel C., Gruel N., Venot C., Debussche L., Conseiller E., Dureuil C., Teillaud J.L., Tocque B., Bracco L. Oncogene. 18:1999;551-557.
8. Blaydes J.P., Hupp T.R. Oncogene. 17:1998;1045-1052.
9. Shieh S.Y., Ikeda M., Taya Y., Prives C. Cell. 91:1997;325-334.
10. Lambert P.F., Kashanchi F., Radonovich M.F., Shiekhattar R., Brady J.N. J. Biol. Chem. 273:1998;33048-33053.
11. Hupp T.R., Lane D.P. J. Biol. Chem. 270:1995;18165-18174.
12. Craig A.L., Burch L., Vojtesek B., Mikutowska J., Thompson A., Hupp T.R. Biochem. J. 342:1999;133-141.
13. Chen J., Mareschal V., Levine A.J. Mol. Cell. Biol. 13:1993;4107-4114.
14. Picksley S.M., Vojtesek B., Sparks A., Lane D.P. Oncogene. 9:1994;2523-2529.
15. Kussie H., Gorina S., Marechal V., Elenbaas B., Moreau J., Levine A.J., Pavletich N.P. Science. 274:1996;948-953.
16. Unger T., Juven-Gershon T., Moallem E., Berger M., Vogt Sionov R., Lozano G., Oren M., Haupt Y. EMBO J. 18:1999;1805-1814.
17. Brown D.R., Deb S., Munoz R.M., Subler M.A., Deb S.P. Mol. Cell Biol. 13:1993;6849-6857.
18. Marston N.J., Jenkins J.R., Vousden K.H. Oncogene. 10:1995;1709-1715.
19. Kubbutat M.H., Ludwig R.L., Ashcroft M., Vousden K.H. Mol. Cell Biol. 18:1998;5690-5698.
20. Elenbaas B., Dobbelstein M., Roth J., Shenk T., Levine A.J. Mol. Med. 2:1996;439-451.
21. Freemont P.S. Ann. N.Y. Acad. Sci. 684:1993;174-192.
22. Midgley C.A., Fisher C.J., Bartek J., Vojtesek B., Lane D.P., Barnes D.M. J. Cell. Sci. 101:1992;183-189.
23. Hansen S., Hupp T.R., Lane D.P. J. Biol. Chem. 271:1996;3917-3924.
24. Stephen C.W., Helminen P., Lane D.P. J. Mol. Biol. 248:1995;58-78.
25. Hupp T.R. Cell Mol. Life Sci. 55:1999;88-95.
26. Jeffrey P.D., Gorina S., Pavletich N.P. Science. 267:1995;1498-1502.
27. Hay B.A., Wasserman D.A., Rubin G.M. Cell. 83:1995;1253-1262.
28. Marechal V., Elenbaas B., Taneyhill L., Piette J., Mechali M., Nicolas J.C., Levine A.J., Moreau J. Oncogene. 14:1997;1427-1433.
29. Borden K.L., Campbell-Dwyer E.J., Salvato M.S. FEBS Lett. 418:1997;30-34.
30. Borden K.L., Campbell-Dwyer E.J., Salvato M.S. J. Virol. 72:1998;758-766.